AccessPak for HIV PEP Expanded with Kaletra and Romosozumab-aqqg

• Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: AccessPak for HIV PEP Expanded with Kaletra

AccessPak for HIV PEP Expanded with Kaletra are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body.

AccessPak for HIV PEP Expanded with Kaletra is a combination medicine used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). AccessPak for HIV PEP Expanded with Kaletra is not a cure for HIV or AIDS.

AccessPak for HIV PEP Expanded with Kaletra may also be used for purposes not listed in this medication guide.

• Generic Name: romosozumab
• Dosage Forms: n.a.
• Other Brand Names: Evenity

Romosozumab-aqqg is a sclerostin inhibitor indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

Limit duration of use to 12 monthly doses. If osteoporosis therapy remains warranted, continued therapy with an anti-resorptive agent should be considered.